A recent report has shown that altered BRCA1 expression in peripheral T cells could result in aberrant transcription related to antitumor immunity, which may contribute to the elevated breast cancer risk among BRCA1-mutation-carrying women [22]. This evidence concerns the gene BRCA1 and breast carcinoma.